RXST Q1 2023 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena

RXSTRxSight, Inc.

$313M

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$17M+95.6% YoY

Gross Profit

$10M59.3% margin

Operating Income

-$13M-74.9% margin

Net Income

-$13M-75.5% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

+8.7%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$203M

Total Liabilities

$58M

Stockholders' Equity

$145M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$9M	+95.6%
Gross Profit	$10M	$4M	+175.6%
Operating Income	-$13M	-$17M	+21.0%
Net Income	-$13M	-$18M	+24.9%

Revenue Segments

L D D

$6M91%

Service Warranty Service Contracts And Accessories

$619,0009%